Monod Bio
AI-Powered Protein Design
United States · Founded 2022 · $25.3M raised
- Founded
- 2022
- Business Model
- B2B
- Website
- monod.bio
- Total Funding
- $25.3M
- Last Round
- $290K GrantJan 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Diagnostic intervention under Global Health Security Fund
Summary
Monod Bio is a Biotech company based in United States, founded in 2022. It has raised $25.3M in total across 2 rounds, most recently a $290K Grant round in Jan 2024.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2024
Sign up to see all 2 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/monod-bio"><img src="https://indexed.vc/api/badge/company/monod-bio" alt="Monod Bio on Indexed.vc" width="260" height="76" /></a>